Abdelrahman Mahmoud: Clinical Trials

2 trials sponsored by Abdelrahman Mahmoud, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1

Follow Abdelrahman Mahmoud: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Empagliflozin (oral), Placebo - Metabolic Syndrome, Obesity & Overweight
Phase 2RecruitingAbdelrahman Mahmoud662025-09-012026-01-13
Vitamin D Supplementation in Breast Cancer Patients
Vitamin D (Cholecalciferol ) - Peripheral Neuropathic Pain
Phase 2Not yet recruitingAbdelrahman Mahmoud1322024-10-152024-09-19

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Body Weight (1)  ·  Breast Neoplasms (1)  ·  Metabolic Syndrome (1)  ·  Neuralgia (1)  ·  Obesity (1)  ·  Overweight (1)

Interventions

Cholecalciferol (1)  ·  empagliflozin (1)

Countries

Egypt (2)

Top investigators

Abedalrahman Dosoky (1)  ·  Ahmed Kamel (1)  ·  Maggie Abbassi, Prof. (1)